# US 2003/0077591 A1 · Nucleic acid for regulating the ABCA7 gene, molecules modulating its activity and therapeutic applications

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2003/0077591 A1
- Document ID: US20030077591A1
- Status: Published application
- Kind: A1
- Application number: 09/983,446
- Filed: 2001-10-24
- Published: 2003-04-24
- Earliest claimed: 2000-11-28
- Inventors: Patrice Denefle; Marie-Francoise Rosier-Montus; Catherine Prades; Isabelle Arnould-Reguigne; Jose Osorio Y Fortea; Nicolas Duverger; Giovanna Chimini
- Web page: https://patentgrep.com/patent/US20030077591A1

## CPC

- C07K 14/705: Receptors; Cell surface antigens; Cell surface determinants {(tumour specific antigens C07K14/4748)}
- C12N 15/85: for animal cells
- A01K 2217/05: Animals comprising random inserted nucleic acids (transgenic)
- C12N 2830/00: Vector systems having a special element relevant for transcription
- C12N 2830/85: mammalian
- C07K: PEPTIDES (peptides in foodstuffs A23; obtaining protein compositions for foodstuffs, working-up proteins for foodstuffs A23J; preparations for medicinal purposes A61K; peptides containing beta-lactam rings C07D; cyclic dipeptides not having in their molecule any other peptide link than those which form their ring, e.g. piperazine-2,5-diones, C07D; ergot alkaloids of the cyclic peptide type C07D519/02; macromolecular compounds having statistically distributed amino acid units in their molecules, i.e. when the preparation does not provide for a specific; but for a random sequence of the amino acid units, homopolyamides and block copolyamides derived from amino acids C08G69/00; macromolecular products derived from proteins C08H1/00; preparation of glue or gelatine C09H; single cell proteins, enzymes C12N; genetic engineering processes for obtaining peptides C12N15/00; compositions for measuring or testing processes involving enzymes C12Q; investigation or analysis of biological material G01N33/00)
- C12N: MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA (microbiological testing media C12Q1/00)
- A01K: ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS

## Abstract

The present invention relates to nucleic acid sequences that regulate the transcription of the ABCA7 gene, which may be involved in the metabolism of lipids in hematopoietic tissues, as well as in cell signaling mechanisms linked to the immune reaction and to inflammation. The invention also relates to polypeptides and polynucleotides that may be involved in diseases associated with the genetic locus q13 of chromosome 19.

## Claims

### Claim 1

Nucleic acid comprising a polynucleotide having at least 20 consecutive nucleotides having the nucleotide sequence chosen from the sequences SEQ ID No. 1-5, or a nucleic acid having a complementary sequence.

### Claim 2 (depends on 1)

Nucleic acid having at least 80% nucleotide identity with a nucleic acid according to claim 1.

### Claim 3 (depends on 1, 2)

Nucleic acid hybridizing, under high stringency hybridization conditions, with a nucleic acid according to claim 1 or 2.

### Claim 4 (depends on 1, 2, 3)

Nucleic acid according to one of claims 1 to 3, capable of modulating the transcription of a polynucleotide placed under its control.

### Claim 5 (depends on 4)

Nucleic acid according to claim 4, comprising a polynucleotide ranging from the nucleotide at position −1 to the nucleotide at position −1111 relative to the first nucleotide transcribed, located at position 1112 of the nucleotide sequence SEQ ID No. 1.

### Claim 6 (depends on 4)

Nucleic acid according to claim 4, capable of activating the transcription of a polynucleotide of interest placed under its control.

### Claim 7 (depends on 4)

Nucleic acid according to claim 4, capable of inhibiting the transcription of a polynucleotide of interest placed under its control.

### Claim 8 (depends on 1, 2, 3, 4, 5, 6, 7)

Nucleic acid comprising:
a) a nucleic acid according to one of claims 1 to 7; and
b) a polynucleotide encoding a polypeptide or a nucleic acid of interest.

### Claim 9 (depends on 8)

Nucleic acid according to claim 8, characterized in that the nucleic acid of interest is an oligonucleotide of the sense or antisense type.

### Claim 10 (depends on 1, 2, 3, 4, 5, 6, 7, 8, 9)

Recombinant cloning and/or expression vector comprising a nucleic acid according to one of claims 1 to 9.

### Claim 11 (depends on 1, 2, 3, 4, 5, 6, 7, 8, 9, 10)

Host cell transformed with a nucleic acid according to one of claims 1 to 9 or with a recombinant vector according to claim 10.

### Claim 12 (depends on 1, 2, 3, 4, 5, 6, 7, 8, 9, 10)

Nonhuman transgenic mammal whose somatic cells and/or germ cells have been transformed with a nucleic acid according to one of claims 1 to 9 or with a recombinant vector according to claim 10.

### Claim 13 (depends on 8, 11)

Method for screening a substance or a molecule modulating the transcription of the constitutive polynucleotide of the nucleic acid according to claim 8, characterized in that it comprises the following steps:
a) culturing a host cell transformed according to claim 11;
b) incubating the transformed host cell in the presence of the candidate substance or molecule;
c) detecting the expression of the polynucleotide of interest;
d) comparing the results of the detection obtained in step c) with the results of the detection obtained by culturing the transformed host cell in the absence of the candidate molecule or substance.

### Claim 14 (depends on 8, 11)

Kit or box for the in vitro screening of a candidate molecule or substance modulating the transcription of the polypeptide of interest encoded by a constitutive polynucleotide of the nucleic acid according to claim 8, comprising:
a) a host cell transformed according to claim 11;
b) where appropriate, the means necessary for the detection of the transcription of the constitutive polynucleotide of interest of the nucleic acid according to claim 8.

### Claim 15 (depends on 8, 12)

Method of in vivo screening of a substance or molecule modulating the transcription of a constitutive polynucleotide of interest of the nucleic acid according to claim 8, characterized in that it comprises the following steps:
a) administering the candidate substance or molecule to a nonhuman transgenic mammal according to claim 12;
b) detecting the expression of the polynucleotide of interest in the transgenic mammal as treated in step a);
c) comparing the results of detection of step b) to the results observed with a nonhuman transgenic mammal according to claim 12 which has not received the administration of the candidate substance or molecule.

### Claim 16 (depends on 8, 12)

Kit or box for the in vivo screening of a candidate molecule or substance modulating the transcription of the constitutive polynucleotide of interest of the nucleic acid according to claim 8, comprising:
a) a nonhuman transgenic mammal according to claim 12;
b) where appropriate, the means necessary for the detection of the transcription of said polynucleotide of interest.

### Claim 17 (depends on 8)

Substance or molecule modulating the transcription of a constitutive polynucleotide of interest of the nucleic acid according to claim 8.

### Claim 18 (depends on 13, 15, 17)

Substance or molecule according to claim 17, characterized in that it is selected according to the method of claim 13 or of claim 15.

### Claim 19 (depends on 17, 18)

Pharmaceutical composition comprising, as active ingredient, a substance or a molecule according to either of claims 17 and 18.

### Claim 20 (depends on 19)

Pharmaceutical composition according to claim 19, characterized in that it is intended for the treatment and/or prevention of deficiencies in the metabolism of lipids, or in the mechanisms involving the immune system and inflammation.

### Claim 21 (depends on 17, 18)

Substance or molecule according to either of claims 17 and 18, as active ingredient for a medicament.

### Claim 22

Method of detecting an impairment of the transcription of the ABCA7 gene in a subject, comprising the following steps:
a) extracting the total messenger RNA from a biological material obtained from the subject to be tested;
b) quantifying the messenger RNA for ABCA7 present in said biological material;
c) comparing the quantity of messenger RNA for ABCA7 obtained in step b) with the quantity of messenger RNA for ABCA7 expected in a normal subject.

### Claim 23

Method of detecting an impairment of the transcription of the ABCA7 gene in a subject, comprising the following steps:
a) sequencing, from a biological material obtained from the subject to be tested, a polynucleotide located upstream of the site of initiation of transcription of the ABCA7 gene;
b) aligning the nucleotide sequence obtained in a) with the sequence SEQ ID No. 1;
c) determining the various nucleotides between the sequenced polynucleotide obtained from the biological material of the subject to be tested and the reference sequence SEQ ID No. 1.

### Claim 24

Kit or box for the detection of an impairment of the transcription of the ABCA7 gene in a subject, comprising the means necessary for quantifying the messenger RNA for ABCA7 in a biological material obtained from said subject to be tested.

### Claim 25

Kit or box for the detection of an impairment of the transcription of the ABCA7 gene in a subject, comprising the means necessary for the sequencing of a polynucleotide located upstream of the site of initiation of transcription of the ABCA7 gene in the subject to be tested.

### Claim 26 (depends on 1, 2, 3, 4, 5, 6, 7, 8, 9, 10)

Method of screening a molecule or substance modulating the transcription of the constitutive polynucleotide of interest of the nucleic acid according to claim 8, comprising the following steps:
a) incubating a nucleic acid according to one of claims 1 to 9 or a recombinant vector according to claim 10 with a candidate molecule or substance to be tested;
b) detecting the complex formed between the candidate molecule or substance and the candidate molecule or substance.

### Claim 27 (depends on 1, 2, 3, 4, 5, 6, 7, 8, 9, 10)

Kit or box for the screening of a candidate molecule or substance modulating the transcription of the constitutive polynucleotide of interest of the nucleic acid according to claim 8 comprising:
a) a nucleic acid according to one of claims 1 to 9 or a recombinant vector according to claim 10;
b) where appropriate, the means necessary for the detection of the complex formed between the candidate molecule or substance and said nucleic acid.
